BioMarin Pharma (BMRN) Prices 7.5M Common Stock Offering at $96/Share
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
BioMarin Pharma's (BMRN) 7.5M Common Stock Offering Prices at $96/Share
August 9, 2016 9:02 AM EDTBioMarin Pharma's (NASDAQ: BMRN) 7.5M Common Stock Offering Prices at $96/Share
Update from press release:
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today the pricing of an underwritten public offering of 7,500,000 shares of its common... More
BioMarin Pharma (BMRN) Announces 7.5M Share Common Stock Offering
August 8, 2016 4:33 PM EDTBioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced an offering, subject to market and other conditions, of 7,500,000 shares of its common stock in an underwritten public offering. BioMarin has also granted the underwriters a 30-day option to purchase an additional 750,000 shares of common stock. BioMarin intends to use the net proceeds from the offering for general corporate purposes, including... More